Nevada Chapter of the American College of Cardiology

Revascularization for Ischemic Ventricular Dysfunction
The goal of the REVIVED-BCIS2 trial was to evaluate percutaneous coronary intervention (PCI) plus optimal medical therapy compared with optimal medical therapy alone among individuals with left ventricular ejection fraction (LVEF) ≤35% and extensive coronary artery disease (CAD).
CV Sports Chat: Dilated Aortas in Athletes
"CV Sports Chat"â€¯is an interview series including expert discussions relative to sports and exercise cardiology and the health care management of athletes.
Temporary Mechanical Circulatory Support in Infarct-Related CS
What is the effect of early routine active percutaneous mechanical circulatory support (MCS) versus control treatment on 6-month all-cause mortality in patients with acute myocardial infarction-related cardiogenic shock (AMICS)?
Anticoagulation in Device-Detected AF With or Without Vascular Disease
What is the impact of concomitant vascular disease on the benefits and risks of anticoagulation for patients with device-detected atrial fibrillation (DDAF)?
Semaglutide in HFpEF: Pooled Analysis of Four Randomized Trials
Does semaglutide reduce risk for adverse cardiovascular (CV) events in patients with heart failure with preserved ejection fraction (HFpEF)?